Dr.

Abdul Rao On
Transplant Immunology
Transplant Immunology is known as a
providential cure in medical sciences. People
recommend it to patients for getting rid of
many kinds of problems which are related to
health. It involves a surgical operation where
a body part is removed from one location and
transplanted to another. It is done for getting
rid of various health associated problems.
The whole concept of transplantation involves
dealing with the immune tissues for better
health. The process includes important
tissues for the transplantation which includes
autograft, isograft, allograft and xenograft. In
the US, there are many transplantation
institutes and healthcare centers for
transplant immunology facilities.
For example, USF Health is a leading facility
that offers expert doctors and other facilities
to accomplish transplantation activities. The
institute aims to ameliorate health in the
wider environment, in communities, and for
specific individuals.
Earlier the transplantation activity was limited
and very expensive, but, as the demand kept
increasing, these facilities underwent a
revolution and they are nowadays widely used.
Dr. Abdul Rao is a famous transplant
immunologist and an acclaimed transplant
immunologist in the field of medical sciences.
He is highly educated and thoroughly
experienced. He has graduated from the
University of Oxford with a D.Phil in
Transplantation Immunology in 1993. Dr.
Abdul Rao also joined the University of
Pittsburgh in 1993 where he chaired as the
Director of the Section of Cellular
Transplantation and the Section of Medical
Informatics, Thomas E. Starzl
Transplantation Institute.
At USF, Dr. Abdul Rao has also served as the
Associate Director of Translational Research
at USF and as an Associate Professor of
Surgery as well as Pathology. Dr. Abdul Rao's
area of research interest lies on the bench to
bedside (and reverse) translation of novel
therapeutic strategies that are aimed at
alleviating a clinical problem.
Dr. Abdul Rao and his team also worked on the
protocol for induction of donor-specific
tolerance in organ allograft recipients (funded
by National Institutes of Health); cellular
therapeutic treatment of refractory post-
transplant lymphoproliferative disorders
(funded by Cancer Research Treatment
Foundation);
islet cell transplantation to reverse type I
insulin-dependent diabetes (funded by
National Institutes of Health and the Juvenile
Diabetes Foundation International);
transmission of infection following animals to
humans (funded by an extramural grant)
organ and cell transplantation.